Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| bluebird bio, Inc. | 47,787 | reported | 05 Apr 2021 | tx 392+731,927−713,456 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 05 Apr 2021 | SALE | bluebird bio, Inc. | 42 | 30.21 USD | anomaly |
| 02 Mar 2021 | SALE | bluebird bio, Inc. | 42 | 29.58 USD | anomaly |
| 16 Feb 2021 | GRANT_AWARD | bluebird bio, Inc. | 10,000 | 0.00 USD | |
| 17 Feb 2021 | SALE | bluebird bio, Inc. | 698 | 28.16 USD | |
| 16 Feb 2021 | GRANT_AWARD | bluebird bio, Inc. | 2,271 | 0.00 USD | |
| 16 Feb 2021 | GRANT_AWARD | bluebird bio, Inc. | 20,000 | 0.00 USD | deriv |
| 02 Feb 2021 | SALE | bluebird bio, Inc. | 63 | 45.93 USD | |
| 06 Jan 2021 | SALE | bluebird bio, Inc. | 1,843 | 44.76 USD | |
| 06 Jan 2021 | SALE | bluebird bio, Inc. | 1,324 | 45.46 USD | |
| 05 Jan 2021 | SALE | bluebird bio, Inc. | 48 | 44.95 USD | |
| 02 Dec 2020 | SALE | bluebird bio, Inc. | 62 | 46.19 USD | |
| 02 Dec 2020 | SALE | bluebird bio, Inc. | 2 | 46.50 USD | anomaly |
| 02 Nov 2020 | SALE | bluebird bio, Inc. | 6 | 54.43 USD | anomaly |
| 02 Nov 2020 | SALE | bluebird bio, Inc. | 12 | 53.83 USD | anomaly |
| 02 Nov 2020 | SALE | bluebird bio, Inc. | 45 | 52.51 USD | |
| 02 Oct 2020 | SALE | bluebird bio, Inc. | 64 | 52.77 USD | |
| 03 Sept 2020 | SALE | bluebird bio, Inc. | 41 | 58.60 USD | |
| 03 Aug 2020 | SALE | bluebird bio, Inc. | 31 | 60.32 USD | |
| 03 Aug 2020 | SALE | bluebird bio, Inc. | 11 | 61.98 USD | anomaly |
| 02 Jul 2020 | SALE | bluebird bio, Inc. | 42 | 61.57 USD | |
| 02 Jun 2020 | SALE | bluebird bio, Inc. | 10 | 63.36 USD | anomaly |
| 02 Jun 2020 | SALE | bluebird bio, Inc. | 32 | 64.24 USD | |
| 01 May 2020 | GRANT_AWARD | bluebird bio, Inc. | 1,615 | 0.00 USD | |
| 02 Mar 2020 | GRANT_AWARD | bluebird bio, Inc. | 10,000 | 0.00 USD | |
| 02 Mar 2020 | GRANT_AWARD | bluebird bio, Inc. | 20,000 | 0.00 USD | deriv |